AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34473029 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical treatment with complete revascularization
Number of subjects: 29
Study 34473029 — intervention group
Group type: COMPARATOR
Intervention: Conservative medical treatment with incomplete revascularization
Number of subjects: 29
Study 34473029 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete revascularization
Number of subjects: 29
Study 34473029 — intervention group
Group type: EXPERIMENTAL
Intervention: Recanalization of culprit vessels
Number of subjects: 29
Study 34473029 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical treatment
Number of subjects: 29
Study 35734514 — intervention group
Group type: EXPERIMENTAL
Intervention: Thiamine mononitrate 500 mg for 90 days
Number of subjects: 24
Study 35734514 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 90 days
Number of subjects: 24
Study 33058401 — intervention group
Group type: EXPERIMENTAL
Intervention: Pamphlet on paediatric eye health
Number of subjects: 518
Study 33058401 — intervention group
Group type: COMPARATOR
Intervention: Pamphlet on infant play (control)
Number of subjects: 518
Study 36430081 — intervention group
Group type: EXPERIMENTAL
Intervention: IMB‐based health education intervention
Number of subjects: 119
Study 36430081 — intervention group
Group type: COMPARATOR
Intervention: Standard care session (control group)
Number of subjects: 119
Study 34262398 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal testosterone gel (TTG) for 4 weeks
Number of subjects: 122
Study 34262398 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal testosterone gel (TTG) for 6 weeks
Number of subjects: 122
Study 34262398 — intervention group
Group type: COMPARATOR
Intervention: Control group (no TTG)
Number of subjects: 122
Study 33143538 — intervention group
Group type: EXPERIMENTAL
Intervention: Mirtazapine
Number of subjects: 0
Study 33143538 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 36213928 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 Hz rTMS
Number of subjects: 47
Study 36213928 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 47
Study 35234730 — intervention group
Group type: EXPERIMENTAL
Intervention: Unreamed intramedullary nailing
Number of subjects: 55
Study 35234730 — intervention group
Group type: COMPARATOR
Intervention: External fixation
Number of subjects: 55
Study 33465457 — intervention group
Group type: EXPERIMENTAL
Intervention: Omalizumab
Number of subjects: 3139
Study 33465457 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 3139
Study 35328874 — intervention group
Group type: EXPERIMENTAL
Intervention: Task-oriented training
Number of subjects: 20
Study 35328874 — intervention group
Group type: COMPARATOR
Intervention: Table-top activity training
Number of subjects: 20
Study 35328874 — intervention group
Group type: COMPARATOR
Intervention: Task-oriented training and Table-top activity training
Number of subjects: 20
Study 32769596 — intervention group
Group type: EXPERIMENTAL
Intervention: Electromagnetic-focused extracorporeal shockwave treatment (F-ESWT) with energy flux density of 0.20 mJ/mm
Number of subjects: 103
Study 32769596 — intervention group
Group type: COMPARATOR
Intervention: Sham F-ESWT with energy flux density of 0.01 mJ/mm
Number of subjects: 103
Study 32769596 — intervention group
Group type: EXPERIMENTAL
Intervention: F-ESWT group
Number of subjects: 103
Study 32769596 — intervention group
Group type: EXPERIMENTAL
Intervention: F-ESWT in association with a specific exercise program
Number of subjects: 103
Study 35745278 — intervention group
Group type: EXPERIMENTAL
Intervention: Two whole eggs with 70 g of spinach/day (EGG)
Number of subjects: 24
Study 35745278 — intervention group
Group type: COMPARATOR
Intervention: Egg substitute with spinach (SUB)
Number of subjects: 24
Study 34187492 — intervention group
Group type: EXPERIMENTAL
Intervention: Flexible diet (FLEX)
Number of subjects: 23
Study 34187492 — intervention group
Group type: COMPARATOR
Intervention: Rigid diet (RIGID)
Number of subjects: 23
Study 35978353 — intervention group
Group type: EXPERIMENTAL
Intervention: WeChat-based cognitive behavioral therapy intervention
Number of subjects: 76
Study 35978353 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 76
Study 33209182 — intervention group
Group type: EXPERIMENTAL
Intervention: Community-Based Health Insurance (CBHI)
Number of subjects: 75
Study 33209182 — intervention group
Group type: EXPERIMENTAL
Intervention: Proposed solutions for CBHI
Number of subjects: 75
Study 34775775 — intervention group
Group type: EXPERIMENTAL
Intervention: ACP discussions with trained nurses
Number of subjects: 230
Study 32968936 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin
Number of subjects: 162
Study 32968936 — intervention group
Group type: COMPARATOR
Intervention: Routine symptomatic treatment (Control)
Number of subjects: 162
Study 35861952 — intervention group
Group type: EXPERIMENTAL
Intervention: VR‐BiT (Virtual Reality Body Image Training)
Number of subjects: 17
Study 33453498 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-session transcranial Direct Current Stimulation (tDCS)
Number of subjects: 24
Study 33453498 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 24
Study 33453498 — intervention group
Group type: EXPERIMENTAL
Intervention: SZ patients
Number of subjects: 24
Study 32858333 — intervention group
Group type: EXPERIMENTAL
Intervention: Insufficient Sleep (6.5 hours in bed)
Number of subjects: 30
Study 32858333 — intervention group
Group type: COMPARATOR
Intervention: Sufficient Sleep (9.5 hours in bed)
Number of subjects: 30
Study 36309128 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcatheter aortic valve replacement (TAVR)
Number of subjects: 456
Study 36309128 — intervention group
Group type: COMPARATOR
Intervention: Surgical aortic valve replacement (SAVR)
Number of subjects: 456
Study 34617959 — intervention group
Group type: COMPARATOR
Intervention: Standard-dose heparins
Number of subjects: 253
Study 34617959 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic-dose LMWH (enoxaparin, 1 mg/kg subcutaneous, twice daily)
Number of subjects: 253
Study 34617959 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic-dose heparins
Number of subjects: 253
Study 34617959 — intervention group
Group type: COMPARATOR
Intervention: Standard-dose heparins (non-ICU)
Number of subjects: 253
Study 34617959 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic-dose heparins (non-ICU)
Number of subjects: 253
Study 34617959 — intervention group
Group type: COMPARATOR
Intervention: Standard-dose heparins (ICU)
Number of subjects: 253
Study 34617959 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapeutic-dose heparins (ICU)
Number of subjects: 253
Study 32616433 — intervention group
Group type: EXPERIMENTAL
Intervention: Aflibercept (AFL) with FOLFIRI
Number of subjects: 0
Study 32616433 — intervention group
Group type: EXPERIMENTAL
Intervention: Ramucirumab (RAM) with FOLFIRI
Number of subjects: 0
Study 32616433 — intervention group
Group type: COMPARATOR
Intervention: FOLFIRI alone
Number of subjects: 0
Study 33241725 — intervention group
Group type: EXPERIMENTAL
Intervention: Tapentadol prolonged release (PR)
Number of subjects: 0
Study 32492084 — intervention group
Group type: EXPERIMENTAL
Intervention: Convalescent plasma therapy in addition to standard treatment (n=52)
Number of subjects: 103
Study 32492084 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment alone (control) (n=51)
Number of subjects: 103
Study 35784436 — intervention group
Group type: EXPERIMENTAL
Intervention: mCCT (high amount ∼USD 15 per fully immunized child)
Number of subjects: 11197
Study 35784436 — intervention group
Group type: EXPERIMENTAL
Intervention: mCCT (low amount ∼USD 5 per fully immunized child)
Number of subjects: 11197
Study 35784436 — intervention group
Group type: EXPERIMENTAL
Intervention: Certain payment design
Number of subjects: 11197
Study 35784436 — intervention group
Group type: EXPERIMENTAL
Intervention: Airtime payment method
Number of subjects: 11197
Study 35784436 — intervention group
Group type: COMPARATOR
Intervention: SMS reminder only
Number of subjects: 11197
Study 35784436 — intervention group
Group type: EXPERIMENTAL
Intervention: Flat payment schedule
Number of subjects: 11197
Study 33316165 — intervention group
Group type: EXPERIMENTAL
Intervention: Activity trackers with 5 daily alarms
Number of subjects: 48
Study 33316165 — intervention group
Group type: COMPARATOR
Intervention: Activity trackers alone
Number of subjects: 48
Study 35101885 — intervention group
Group type: COMPARATOR
Intervention: pembrolizumab
Number of subjects: 0
Study 35101885 — intervention group
Group type: COMPARATOR
Intervention: atezolizumab
Number of subjects: 0
Study 35101885 — intervention group
Group type: COMPARATOR
Intervention: cemiplimab‐rwlc
Number of subjects: 0
Study 34865335 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical acupoint stimulation (TEAS) for 30 min (8‐12 mA) immediately after surgery
Number of subjects: 60
Study 34865335 — intervention group
Group type: COMPARATOR
Intervention: Control group (no TEAS)
Number of subjects: 60
Study 35355160 — intervention group
Group type: EXPERIMENTAL
Intervention: U-net
Number of subjects: 796
Study 35355160 — intervention group
Group type: EXPERIMENTAL
Intervention: Attention U-net
Number of subjects: 796
Study 35355160 — intervention group
Group type: EXPERIMENTAL
Intervention: CE-net
Number of subjects: 796
Study 35355160 — intervention group
Group type: EXPERIMENTAL
Intervention: U-net with ResNet
Number of subjects: 796
Study 35355160 — intervention group
Group type: EXPERIMENTAL
Intervention: Automatic segmentation
Number of subjects: 796
Study 33017060 — intervention group
Group type: EXPERIMENTAL
Intervention: Reinforced PTFE membranes (Group A)
Number of subjects: 40
Study 33017060 — intervention group
Group type: EXPERIMENTAL
Intervention: Titanium meshes plus collagen membranes (Group B)
Number of subjects: 40
Study 33017060 — intervention group
Group type: COMPARATOR
Intervention: Both groups (A and B)
Number of subjects: 40
Study 35585556 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-cycle intrathecal therapy with two repeated injections of BM-MSCs (Lenzumestrocel) with a 26-day interval
Number of subjects: 115
Study 35585556 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-cycle intrathecal therapy with two repeated injections of BM-MSCs (Lenzumestrocel) with a 26-day interval + three additional booster injections at 4, 7, and 10 months
Number of subjects: 115
Study 33689236 — intervention group
Group type: EXPERIMENTAL
Intervention: Continuous infusion (CI) of furosemide
Number of subjects: 0
Study 33689236 — intervention group
Group type: COMPARATOR
Intervention: Bolus injection (BI) of furosemide
Number of subjects: 0
Study 32301113 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-hour partograph action line
Number of subjects: 640
Study 32301113 — intervention group
Group type: COMPARATOR
Intervention: 4-hour partograph action line
Number of subjects: 640
Study 36216218 — intervention group
Group type: EXPERIMENTAL
Intervention: Quadriceps tendon autograft (QT-A)
Number of subjects: 90
Study 36216218 — intervention group
Group type: COMPARATOR
Intervention: Hamstring tendon autograft (HT-A)
Number of subjects: 90
Study 34053861 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab (200 mg)
Number of subjects: 290
Study 34053861 — intervention group
Group type: COMPARATOR
Intervention: Pembrolizumab (200 mg) plus carboplatin (AUC 5) plus pemetrexed (500 mg/m2)
Number of subjects: 290
Study 32356489 — intervention group
Group type: EXPERIMENTAL
Intervention: Advance care planning discussions before illness
Number of subjects: 700
Study 32356489 — intervention group
Group type: EXPERIMENTAL
Intervention: Factors associated with willingness before illness in Japan
Number of subjects: 700
Study 32356489 — intervention group
Group type: EXPERIMENTAL
Intervention: Factors associated with willingness before illness in Taiwan
Number of subjects: 700
Study 32356489 — intervention group
Group type: EXPERIMENTAL
Intervention: Attitudes towards advance care planning discussions
Number of subjects: 700
Study 32356489 — intervention group
Group type: EXPERIMENTAL
Intervention: Healthcare providers' initiative for discussions
Number of subjects: 700
Study 36007982 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin glargine 300 U/mL (Gla-300)
Number of subjects: 0
Study 36007982 — intervention group
Group type: COMPARATOR
Intervention: Insulin degludec U100 (iDeg-100)
Number of subjects: 0
Study 34461080 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg sildenafil citrate tablets
Number of subjects: 40
Study 35969004 — intervention group
Group type: EXPERIMENTAL
Intervention: Clazakizumab
Number of subjects: 20
Study 35969004 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 34125743 — intervention group
Group type: EXPERIMENTAL
Intervention: Static core exercises
Number of subjects: 30
Study 34125743 — intervention group
Group type: COMPARATOR
Intervention: Swiss ball training
Number of subjects: 30
Study 32517582 — intervention group
Group type: EXPERIMENTAL
Intervention: Rivaroxaban 15 mg daily
Number of subjects: 7213
Study 32517582 — intervention group
Group type: COMPARATOR
Intervention: Aspirin 100 mg daily
Number of subjects: 7213
Study 33048344 — intervention group
Group type: EXPERIMENTAL
Intervention: Dose-dense weekly paclitaxel with 3-weekly carboplatin
Number of subjects: 246
Study 33048344 — intervention group
Group type: COMPARATOR
Intervention: Standard 3-weekly chemotherapy
Number of subjects: 246
Study 32275352 — intervention group
Group type: EXPERIMENTAL
Intervention: Garcinia kola (bitter kola) 100 mg/kg body weight in a 200 ml solution
Number of subjects: 46
Study 32275352 — intervention group
Group type: COMPARATOR
Intervention: Water (placebo control)
Number of subjects: 46
Study 35844452 — intervention group
Group type: EXPERIMENTAL
Intervention: Bisphosphonate
Number of subjects: 60
Study 35844452 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 60
Study 34498764 — intervention group
Group type: EXPERIMENTAL
Intervention: Filgrastim (FIL)
Number of subjects: 90
Study 34498764 — intervention group
Group type: COMPARATOR
Intervention: Pegfilgrastim (PEG)
Number of subjects: 90
Study 33326335 — intervention group
Group type: EXPERIMENTAL
Intervention: Synchronized intermittent mandatory pressure-controlled ventilation
Number of subjects: 36
Study 33138927 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient motivational enhancement therapy (MET, four sessions)
Number of subjects: 693
Study 33138927 — intervention group
Group type: EXPERIMENTAL
Intervention: Outpatient MET plus community reinforcement approach for seniors (MET & CRA-S; up to 12 sessions)
Number of subjects: 693
Study 34375501 — intervention group
Group type: EXPERIMENTAL
Intervention: Plyometrics exercises
Number of subjects: 200
Study 34375501 — intervention group
Group type: EXPERIMENTAL
Intervention: Balance exercises
Number of subjects: 200
Study 34375501 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of both exercises
Number of subjects: 200
Study 34375501 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 200
Study 34813687 — intervention group
Group type: EXPERIMENTAL
Intervention: RISE (1-6 sessions of psychosocial counseling)
Number of subjects: 60
Study 34813687 — intervention group
Group type: COMPARATOR
Intervention: ECAU (enhanced care as usual, single session of psychoeducation, safety planning, resources, and referrals)
Number of subjects: 60
Study 34625482 — intervention group
Group type: EXPERIMENTAL
Intervention: Guide sheath (GS)
Number of subjects: 596
Study 34625482 — intervention group
Group type: COMPARATOR
Intervention: Non-guide sheath (non-GS)
Number of subjects: 596
Study 33432670 — intervention group
Group type: EXPERIMENTAL
Intervention: Family-focused therapy for high-risk youth (FFT-HR)
Number of subjects: 40
Study 33432670 — intervention group
Group type: COMPARATOR
Intervention: Enhanced Care (EC)
Number of subjects: 40
Study 33432670 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatments
Number of subjects: 40
Study 35500971 — intervention group
Group type: EXPERIMENTAL
Intervention: Static stretching
Number of subjects: 45
Study 35500971 — intervention group
Group type: EXPERIMENTAL
Intervention: Strengthening exercise in lengthened hamstring position
Number of subjects: 45
Study 35500971 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 45
Study 36455146 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined management of weight, blood pressure, and blood lipids
Number of subjects: 380
Study 36455146 — intervention group
Group type: COMPARATOR
Intervention: Anti-atherosclerotic treatments (Control)
Number of subjects: 380
Study 34408252 — intervention group
Group type: EXPERIMENTAL
Intervention: Urea + 5 Mg biochar ha-1 (B5)
Number of subjects: 4
Study 34408252 — intervention group
Group type: EXPERIMENTAL
Intervention: Urea + 10 Mg biochar ha-1 (B10)
Number of subjects: 4
Study 34408252 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 Mg biochar ha-1 (B5)
Number of subjects: 4
Study 34408252 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 Mg biochar ha-1 (B10)
Number of subjects: 4
Study 34408252 — intervention group
Group type: COMPARATOR
Intervention: Control (no biochar or urea)
Number of subjects: 4
Study 34408252 — intervention group
Group type: COMPARATOR
Intervention: Sole urea (150 kg N ha-1)
Number of subjects: 4
Study 35776235 — intervention group
Group type: EXPERIMENTAL
Intervention: Neuropsychological test performance (Amsterdam Cognition Scan)
Number of subjects: 279
Study 35776235 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-reported cognitive functioning (Cognitive Symptom Checklist‐work)
Number of subjects: 279
Study 32972387 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual impairment
Number of subjects: 2599
Study 32972387 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual acuity
Number of subjects: 2599
Study 35940850 — intervention group
Group type: EXPERIMENTAL
Intervention: Cardiac rehabilitation (CR) for 10 weeks, consisting of 3 days/week of interval training at 60-90% of heart rate reserve
Number of subjects: 28
Study 35940850 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 28
Study 32975724 — intervention group
Group type: EXPERIMENTAL
Intervention: Bacillus licheniformis H2 pretreatment
Number of subjects: 180
Study 32975724 — intervention group
Group type: COMPARATOR
Intervention: SNE infection group
Number of subjects: 180
Study 32975724 — intervention group
Group type: COMPARATOR
Intervention: Negative control group
Number of subjects: 180
Study 32065870 — intervention group
Group type: EXPERIMENTAL
Intervention: Trigone-including BTX-A injection template
Number of subjects: 0
Study 32065870 — intervention group
Group type: EXPERIMENTAL
Intervention: Trigone-sparing BTX-A injection template
Number of subjects: 0
Study 32065870 — intervention group
Group type: COMPARATOR
Intervention: Both treatment groups (Trigone-including and Trigone-sparing)
Number of subjects: 0
Study 37947080 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 47
Study 37947080 — intervention group
Group type: COMPARATOR
Intervention: Moderate-Intensity Continuous Training (MICT)
Number of subjects: 47
Study 32955720 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D (50,000 IU weekly) plus magnesium (250 mg daily)
Number of subjects: 83
Study 32955720 — intervention group
Group type: COMPARATOR
Intervention: Vitamin D placebo plus magnesium placebo
Number of subjects: 83
Study 32462950 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-month dietary, exercise, and mindfulness program
Number of subjects: 75
Study 32462950 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG)
Number of subjects: 75
Study 36107646 — intervention group
Group type: COMPARATOR
Intervention: Distraction
Number of subjects: 0
Study 36107646 — intervention group
Group type: COMPARATOR
Intervention: Gratitude
Number of subjects: 0
Study 36107646 — intervention group
Group type: EXPERIMENTAL
Intervention: Rumination
Number of subjects: 0
Study 36379192 — intervention group
Group type: EXPERIMENTAL
Intervention: Cigarettes with varying filter ventilation levels
Number of subjects: 607
Study 33218310 — intervention group
Group type: EXPERIMENTAL
Intervention: Face-to-face intervention CARE-FAM
Number of subjects: 0
Study 33218310 — intervention group
Group type: EXPERIMENTAL
Intervention: Online intervention WEP-CARE
Number of subjects: 0
Study 33218310 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of both CARE-FAM and WEP-CARE interventions
Number of subjects: 0
Study 33218310 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual (Control)
Number of subjects: 0
Study 34340975 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal dexamethasone (DEX-) implant
Number of subjects: 0
Study 34340975 — intervention group
Group type: COMPARATOR
Intervention: Bevacizumab
Number of subjects: 0
Study 34340975 — intervention group
Group type: EXPERIMENTAL
Intervention: Both treatment groups (DEX- implant and bevacizumab)
Number of subjects: 0
Study 33027082 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin use
Number of subjects: 11593409
Study 33027082 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin use with diabetes mellitus (DM)
Number of subjects: 11593409
Study 33027082 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin use without diabetes mellitus (DM)
Number of subjects: 11593409
Study 32327447 — intervention group
Group type: EXPERIMENTAL
Intervention: CRISPR-Cas9 system with single-base mismatched sgRNAs
Number of subjects: 0
Study 32327447 — intervention group
Group type: COMPARATOR
Intervention: CRISPR-Cas9 system without mismatches
Number of subjects: 0
Study 32853739 — intervention group
Group type: EXPERIMENTAL
Intervention: Ministernotomy AVR
Number of subjects: 0
Study 32964296 — intervention group
Group type: EXPERIMENTAL
Intervention: Locked intramedullary nailing
Number of subjects: 50
Study 32964296 — intervention group
Group type: COMPARATOR
Intervention: Plating
Number of subjects: 50
Study 32613563 — intervention group
Group type: EXPERIMENTAL
Intervention: Gaseous ozone application during scaling procedure
Number of subjects: 40
Study 32613563 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving only initial periodontal treatment
Number of subjects: 40
Study 32771983 — intervention group
Group type: EXPERIMENTAL
Intervention: Gastrointestinal care bundle including individualized dietary counselling weekly and rapid-access investigation and treatment for bowel symptoms.
Number of subjects: 50
Study 32771983 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention).
Number of subjects: 50
Study 33593767 — intervention group
Group type: EXPERIMENTAL
Intervention: BCG vaccination
Number of subjects: 0
Study 33593767 — intervention group
Group type: EXPERIMENTAL
Intervention: Yellow fever, oral typhoid, and HPV vaccines
Number of subjects: 0